Opioid addiction treatment helps people address drug use that has become difficult to control and harmful to their health, relationships, safety, or daily functioning. Opioids include prescription pain medications such as oxycodone, hydrocodone, morphine, and fentanyl, as well as illegal opioids such as heroin. These substances can relieve pain and create feelings of calm or euphoria, but they can also cause physical dependence, addiction, respiratory depression, and fatal overdose. At Rainbow Hill Recovery, we provide LGBTQIA+-affirming outpatient opioid addiction treatment in Los Angeles for adults who are medically stable and ready to work toward meaningful recovery.
Our approach recognizes that opioid addiction does not occur separately from a person’s mental health, relationships, identity, trauma history, and daily environment. LGBTQIA+ clients may enter treatment after experiencing rejection, discrimination, identity concealment, harassment, family conflict, or previous healthcare settings where they did not feel understood. Sexual orientation and gender identity do not cause addiction, but identity-related stress can affect emotional health, treatment access, trust, and the ways someone attempts to cope with distress. Affirming care allows clients to discuss these experiences without being judged, stereotyped, misgendered, or asked to hide an important part of themselves.
Opioid addiction is clinically known as opioid use disorder, or OUD. The condition involves a problematic pattern of opioid use that results in significant distress, impairment, or continued harm. Someone may lose control over how much they use, experience persistent cravings, or continue using opioids despite medical, emotional, occupational, financial, or relationship consequences. A diagnosis is based on the overall pattern of behavior rather than one prescription, one episode of misuse, or physical dependence alone.
Opioid use disorder can range from mild to severe depending on the number of recognized symptoms occurring within a 12-month period. The 2024 National Survey on Drug Use and Health estimated that approximately 4.8 million people aged 12 or older had OUD during the previous year. A separate 2024 federal analysis found that only about 19.4% of adults with past-year OUD received medication for the disorder during that period. These figures show both the scale of opioid addiction and the continuing gap between the number of people who need evidence-based care and those who receive it.
Opioids attach to receptors in parts of the brain and body involved in pain, pleasure, stress, reward, and breathing. They may reduce physical pain and create a sense of calm or euphoria, which can strongly reinforce repeated use. Continued exposure can change how the brain responds to the drug and to ordinary sources of pleasure, making other activities feel less satisfying. As the brain and body adapt, the person may need more of the opioid to experience an effect that previously required a smaller amount.
Opioids can also slow breathing, especially when a dose is stronger than expected or is combined with alcohol, benzodiazepines, sleep medications, or other depressants. When breathing becomes dangerously slow or stops, the brain and other organs can be deprived of oxygen, resulting in permanent injury or death. This danger is particularly serious with illegally manufactured fentanyl because it may be present in pills or powders without the person’s knowledge. The contents and strength of an illicit product cannot be reliably determined by its color, shape, packaging, taste, or smell.
There is no single cause of opioid addiction, and developing OUD is not evidence of weak character or insufficient willpower. Risk may be influenced by genetics, family history, repeated opioid exposure, chronic pain, trauma, mental health symptoms, housing instability, financial stress, social isolation, and access to drugs. Some people first encounter opioids after surgery, an injury, or treatment for ongoing pain, while others begin by using pills recreationally or taking medication obtained from another person. Because people reach addiction through different circumstances, treatment must be based on an individualized assessment rather than assumptions about how opioid use began.
Depression, anxiety, post-traumatic stress, grief, loneliness, and unresolved emotional pain may contribute to continued opioid use. A person may initially use an opioid for physical pain and discover that it temporarily reduces fear, shame, sadness, or distress as well. The relief does not last, and the consequences of continued use may eventually worsen the same emotional and practical problems the person was trying to escape. Effective treatment explores what opioids have appeared to provide while helping the client understand what the pattern has taken away.
Opioid addiction may develop gradually, and early warning signs can be mistaken for chronic pain, depression, stress, exhaustion, or medication side effects. A person may continue working, attending school, or caring for family members while privately struggling with cravings and withdrawal. Partners, friends, or relatives may notice changes in alertness, finances, reliability, mood, or behavior before the individual recognizes the severity of the problem. A qualified assessment considers the complete pattern rather than relying on appearance, identity, occupation, or one isolated symptom.
Common signs of opioid use disorder may include:
Not everyone with OUD displays every sign, and the condition may look different from one person to another. One client may appear frequently drowsy or sedated, while another may seem outwardly functional but experience intense anxiety whenever opioids are unavailable. Additional signs can include pinpoint pupils, slurred speech, secrecy, unexplained financial problems, changing social groups, missed appointments, or declining personal care. The pattern becomes especially concerning when opioid use continues despite clear evidence that it is affecting health, safety, relationships, or the ability to function.
Some LGBTQIA+ people experience chronic stress related to rejection, discrimination, violence, identity concealment, family conflict, housing insecurity, or difficulty finding affirming healthcare. These experiences can affect anxiety, depression, trauma responses, social connection, and a person’s willingness to seek treatment. They do not define every LGBTQIA+ client, and an affirming program should never assume that identity-related concerns are central to every person’s opioid use. Treatment should instead provide a safe opportunity to discuss these experiences when they are relevant to the client’s health, recovery, relationships, or sense of safety.
Previous negative treatment experiences may also create barriers to care. A client may worry about being misgendered, having a partner or chosen family excluded, encountering judgment about sexuality, or having legitimate medical concerns dismissed. These fears can delay treatment, reduce openness during assessment, and make it difficult to trust clinicians or recovery groups. LGBTQIA+-affirming opioid treatment should respect each client’s name, pronouns, relationships, identity, culture, privacy, boundaries, and personal recovery goals.
Tolerance develops when repeated opioid exposure causes the body to respond less strongly to the same amount. A person may begin using larger doses, taking opioids more frequently, or changing how the substance is consumed to produce a stronger effect. Tolerance can increase overdose risk because the difference between the desired effect and a dangerous dose may become difficult to predict. Illicit opioids create additional uncertainty because their potency and ingredients may vary considerably from one dose to the next.
Physical dependence means that the body has adapted to the opioid and may experience withdrawal when use is reduced or stopped. Dependence can develop during medically supervised pain treatment and does not automatically mean the person has an addiction. Addiction more commonly involves compulsive behavior, cravings, impaired control, and continued use despite serious consequences. Someone may have physical dependence, opioid use disorder, or both, making an individualized medical and behavioral assessment essential.
Opioid cravings may be triggered by physical pain, anxiety, depression, insomnia, conflict, specific people, familiar locations, prescription bottles, or memories of previous use. LGBTQIA+ clients may also encounter identity-related triggers such as rejection, discrimination, misgendering, isolation, family conflict, or returning to an unsafe environment. Relapse-prevention planning helps clients identify these warning signs and establish specific actions before cravings become overwhelming. A practical plan may include supportive contacts, medication routines, therapy appointments, coping strategies, safe locations, and naloxone access.
Community support can be particularly meaningful for people who have felt uncomfortable or excluded in traditional recovery environments. Clients should not have to repeatedly explain their identity, defend their relationships, or determine whether a support setting will respect their name and pronouns. Affirming peer connections may reduce isolation while providing accountability, shared understanding, and encouragement. Chosen family, partners, supportive relatives, peers, and community resources may all become valuable parts of the client’s recovery network.
Rainbow Hill Recovery’s aftercare services support clients as they transition from structured treatment into greater independence. Continuing care may include individual therapy, support groups, regular check-ins, relapse-prevention education, life-skills resources, and connections to an affirming recovery community. These services give clients a place to address renewed cravings, pain, mental health symptoms, relationship changes, or identity-related stress before those challenges become larger problems. A lapse does not erase previous progress, but it should be addressed quickly because reduced opioid tolerance can increase overdose risk when use resumes.
An opioid overdose occurs when the substance suppresses breathing and other vital functions. Warning signs may include an inability to wake the person, slow or stopped breathing, choking or gurgling noises, a limp body, cold or clammy skin, discolored lips or fingernails, and extremely small pupils. An overdose is a medical emergency even when the exact drug is unknown. Call 911 immediately, administer naloxone when available, and remain with the person until emergency responders arrive.
Naloxone is a medication that can rapidly reverse an opioid overdose involving heroin, fentanyl, or prescription opioids when it is administered in time. It is available in forms that can be used by people without medical training, including a prefilled nasal spray. More than one dose may be necessary when a potent opioid is involved, and emergency assistance is still required even when the person begins breathing again. Partners, chosen family members, roommates, friends, and others in a client’s support system can benefit from knowing where naloxone is stored and how to use it.
National overdose deaths have declined, but the continuing loss of life remains substantial. CDC provisional data released on May 13, 2026, estimated that opioid-involved overdose deaths decreased from 55,296 in 2024 to 44,564 in 2025. The decline represents meaningful progress, yet more than 44,000 estimated opioid-related deaths in one year demonstrate the continued need for treatment, naloxone access, overdose education, and recovery support. The same report noted that Arizona was among the states that experienced an increase rather than a decline, underscoring the uneven nature of the national improvement.
Medications are an important evidence-based treatment option for many people with opioid use disorder. Methadone, buprenorphine, and naltrexone are approved to treat OUD, although they work differently and have different initiation requirements. Methadone and buprenorphine can reduce cravings and withdrawal symptoms, while naltrexone blocks opioid effects after the required opioid-free period. The appropriate medication must be determined by a qualified professional based on the client’s health, current opioid exposure, treatment history, preferences, and clinical needs.
Medication for OUD is not simply replacing one addiction with another. These medications are used within clinical treatment plans to stabilize brain function, reduce cravings, lower overdose risk, and help people remain engaged in recovery. Rainbow Hill Recovery identifies medication-assisted treatment as one component that may be included in its substance use disorder services, together with therapy and trauma-informed care. Medication services may be provided or coordinated according to clinical appropriateness, prescribing requirements, and the client’s individualized plan.
Affirming medication discussions are especially important for clients who have previously experienced stigma within healthcare settings. Treatment decisions should not be influenced by stereotypes about sexual orientation, gender identity, relationship structure, or a person’s appearance. Clinicians should also consider the client’s complete medical picture, including mental health medications, hormone therapy, pain concerns, and other prescribed treatments. The goal is coordinated care that protects health while respecting the client’s identity, autonomy, and informed choices.
Behavioral therapy helps clients understand the thoughts, emotions, relationships, environments, and routines connected to opioid use. Cognitive Behavioral Therapy can help clients recognize automatic thinking patterns and practice healthier responses to cravings, stress, pain, and social pressure. Dialectical Behavior Therapy may strengthen emotional regulation, distress tolerance, mindfulness, and communication skills. Trauma-informed care can help clients address painful experiences without forcing disclosure, creating shame, or treating identity as something that needs to be changed.
Affirmative therapy validates a person’s sexual orientation, gender identity, and lived experience while addressing mental health and substance use concerns. A client may want to discuss coming out, family rejection, gender dysphoria, discrimination, relationship violence, spirituality, chosen family, or safety within the community. Another client may not view identity-related experiences as central to treatment and should not be pressured to explore them. Individualized care allows each person to decide which concerns are relevant while receiving practical help for opioid addiction and recovery.
Opioid withdrawal can occur when someone who has become physically dependent suddenly stops or substantially reduces use. Symptoms may include anxiety, agitation, sweating, yawning, watery eyes, a runny nose, muscle aches, nausea, vomiting, diarrhea, abdominal cramping, insomnia, and intense cravings. The timing and severity can vary according to the opioid, dosage, duration of use, overall health, and whether alcohol or other drugs are also involved. Withdrawal can be extremely uncomfortable and may lead someone to resume opioid use simply to stop the symptoms.
Rainbow Hill Recovery provides outpatient mental health and substance use treatment rather than care for active withdrawal symptoms. A person experiencing significant withdrawal should receive an appropriate medical evaluation before beginning routine outpatient programming. Medical professionals can assess dehydration, pregnancy, other substance use, underlying health concerns, and whether medication or a higher level of care is needed. Once the person is medically stable, our team can evaluate whether PHP, IOP, OP, or Virtual IOP is an appropriate next step.
Rainbow Hill Recovery offers a Partial Hospitalization Program, Intensive Outpatient Program, Outpatient Program, and Virtual IOP for adults who are appropriate for outpatient care. PHP provides the greatest amount of outpatient structure, while IOP offers regular therapy and support with more independence outside treatment hours. OP may be suitable for clients who need flexible continuing care or are transitioning from a more structured program. Virtual IOP provides access to structured treatment from home when telehealth is clinically appropriate for the client’s needs, safety, and living situation.
Program placement is based on medical stability, overdose risk, withdrawal needs, mental health symptoms, opioid-use severity, living conditions, daily responsibilities, and available support. Outpatient care is not appropriate for someone experiencing an active overdose, untreated withdrawal symptoms, severe psychiatric instability, or an inability to meet basic safety needs. Those circumstances may require emergency treatment, medical stabilization, or another level of care before outpatient treatment begins. Once stable, the client may transition into structured programming for therapy, medication support, relapse prevention, and continuing recovery planning.
Rainbow Hill Recovery provides LGBTQIA+-affirming outpatient care for adults who need support addressing opioid use alongside mental health, trauma, relationships, identity, and daily responsibilities. Our available programs allow treatment intensity to be matched to each client’s medical stability, symptoms, strengths, schedule, and recovery goals. Clients may receive individual and group therapy, affirmative and trauma-informed care, psychiatric support, medication-assisted treatment, relapse-prevention education, and personalized continuing-care planning. This coordinated approach helps clients work toward recovery without being asked to hide, defend, or minimize who they are.
A person does not need to wait for an overdose, job loss, damaged relationship, or another severe crisis before asking for help. An assessment can clarify the severity of opioid use, identify co-occurring mental health concerns, determine whether medical stabilization is needed, and establish which outpatient program may be appropriate. Rainbow Hill Recovery combines evidence-based addiction treatment with LGBTQIA+-affirming care, trauma-informed therapy, practical recovery education, and continuing community support. Call (310) 341-4887 to speak with our Los Angeles team about opioid addiction treatment and the next appropriate step.
Joie Gyondla serves as Rainbow Hill Recovery’s Clinical Support Coordinator, bringing compassion, empathy, and a genuine commitment to supporting every client who walks through our doors. With a background in recovery support, Joie understands the importance of creating a welcoming, organized, and affirming environment where individuals feel seen, valued, and supported throughout their treatment journey.
Working closely with both clients and the clinical team, Joie helps ensure that each person’s experience is as seamless as possible, providing encouragement, guidance, and practical support every step of the way. Her calm presence and dedication to helping others foster a sense of safety and connection that allows clients to focus on what matters most: their recovery.
Joie believes that healing begins with compassion and that even the smallest acts of kindness can make a lasting difference. She is proud to be part of the Rainbow Hill Recovery team, helping create a community where every individual is empowered to build a healthier, more authentic future.
Co-Founder of the LGBTQ+ Association for Addiction and Mental Health Professionals Clinical Outreach Specialist for Rainbow Hill Recovery LGBTQ Sensitivity Training Consultant
Steven Buffin-Stewart is the Case Manager at Rainbow Hill Recovery, with over five years of experience in substance use and mental health treatment. A CADC ll professional in recovery themselves, Steven combines clinical knowledge with lived experience to provide compassionate, coordinated care and foster inclusive, affirming spaces where clients feel supported, empowered, and hopeful in their healing journey.
Steven Buffin-Stewart is the Program and Case Manager at Rainbow Hill Recovery, with over five years of experience in substance use and mental health treatment. A CADC ll professional in recovery themselves, Steven combines clinical knowledge with lived experience to provide compassionate, coordinated care and foster inclusive, affirming spaces where clients feel supported, empowered, and hopeful in their healing journey.
Janae Borrego serves as Rainbow Hill Recovery’s Cross-Cultural Relations Officer and Outpatient Therapist, where she combines her clinical expertise with a deep commitment to fostering an inclusive, culturally responsive environment for every client. Her ability to understand, appreciate, and navigate diverse cultural perspectives has made her an invaluable leader as Rainbow Hill continues to grow and evolve.
In her role, Janae works to strengthen cultural understanding throughout the organization, ensuring that clients, families, and staff feel respected, heard, and represented. She provides ongoing guidance on cultural sensitivity and inclusive practices while helping shape programs that honor the unique identities, backgrounds, and lived experiences of those we serve.
As an Outpatient Therapist, Janae is dedicated to helping clients navigate recovery, mental health, and life’s challenges with compassion, authenticity, and evidence-based care. She believes that meaningful healing begins when individuals feel safe to show up as their authentic selves and receive support that acknowledges the whole person.
Janae is passionate about creating spaces where diversity is celebrated, connection is strengthened, and every individual has the opportunity to heal and thrive. Her leadership continues to advance Rainbow Hill Recovery’s mission of providing affirming, trauma-informed care that meets the evolving needs of the communities we serve.
With over a decade of experience in addiction recovery, Andrew is passionate about helping individuals reclaim their lives and find lasting healing. As Co-founder and Director of Rainbow Hill Recovery, he is dedicated to creating a supportive environment that fosters hope, resilience, and transformation.
Joey Bachrach is the Co-Founder and CEO of Rainbow Hill Recovery, an LGBTQ-affirming mental health and substance use treatment center in Los Angeles. Drawing from both professional leadership and lived recovery experience, Joey is dedicated to creating safe, inclusive spaces where individuals are fully seen, affirmed, and supported on their healing journey.